Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3031067	s-hivag	— (—)	183	188	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

8.46

52.61

1.0

—

Second line medication for Crohn's disease

6.43

33.11

1.0

—

L04AX Other immunosuppressants

6.55

33.05

1.0

—

L04AA Selective immunosuppressants

9.70

25.86

1.1

1.0

—

First line medication for Crohn's disease

4.25

20.53

1.0

—

ILD medications

4.10

20.31

1.0

—

Contact with and exposure to communicable diseases

6.51

19.86

1.0

—

Autoimmune diseases related-to ILD

114

4.05

18.85

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.96

18.33

1.0

—

Inflammatory bowel disease treatment related agents

104

3.55

16.69

1.0

—

Fever of other and unknown origin

4.63

16.30

1.0

—

Oral corticosteroids

100

3.62

16.21

1.0

—

Persons with potential health hazards related to communicable diseases

4.96

15.48

1.0

—

Autoimmune diseases excluding thyroid diseases

3.56

15.12

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.59

15.07

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

113

3.36

13.89

1.0

—

Autoimmune diseases

3.32

13.38

1.0

—

Noninfective enteritis and colitis

4.23

12.84

1.0

—

IBD patients in KELA-register

5.76

12.71

1.0

1.1

—

Used for control exclusion in common control thyroid runs

3.21

11.51

1.0

—

Other and unspecified anaemias

4.52

11.26

1.0

1.1

—

Inflammatory bowel disease, strict (require KELA)

5.12

11.24

1.0

—

Other anaemias

4.51

11.22

1.0

1.1

—

Liquid cancers, helper endpoint

4.73

11.12

1.0

1.1

—

Aplastic and other anaemias

4.28

10.87

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.82

10.73

1.0

—

Care involving dialysis

21.52

10.67

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

16.05

10.33

1.1

1.0

—

L04AD Calcineurin inhibitors

14.59

9.98

1.1

—

Nephropathy related operations

12.18

9.83

1.0

—

Dialysis, with operation codes

12.18

9.83

1.0

1.1

—

GASTRO-related operations

3.67

9.76

1.1

1.0

—

Any gastric operation

3.67

9.76

1.1

1.0

—

5-aminosalicylic acid

7.35

9.67

1.0

—

Inflammatory bowel disease

4.29

9.56

1.0

—

Renal failure

4.11

9.45

1.0

—

Pneumonia, organism unspecified

104

2.97

9.31

1.0

—

Diseases of liver

4.14

9.15

1.0

—

Ulcerative colitis

4.76

8.57

1.0

1.1

—

Other diseases of pleura

3.92

8.54

1.1

1.0

—

2.99

8.44

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.99

8.44

1.0

—

Chronic kidney disease

6.77

8.38

1.0

1.1

—

Implicit viral Sepsis

4.87

8.34

1.1

1.0

—

Purpura and other haemorrhagic conditions

9.43

8.26

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

118

2.67

8.22

1.0

—

Sleep apnoea

100

2.78

8.02

1.0

—

Polyarthropathies

2.93

7.96

1.0

—

Secondary hypertension

21.78

7.96

1.0

—

Disorders of other endocrine glands

3.62

7.93

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.11

7.88

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

116

2.65

7.77

1.0

—

Other diseases of the respiratory system

9.39

7.76

1.1

1.0

—

Other respiratory disorders and diseases

9.39

7.76

1.1

1.0

—

Extracorporeal dialysis

18.41

7.60

1.0

—

Covid-19 confirmed case

3.97

7.59

1.0

—

All pneumoniae

120

2.56

7.44

1.0

—

Reimbursement for rheumatic diseases

3.21

7.44

1.0

—

Sulfasalazine

4.39

7.41

1.1

1.0

—

Other diseases of blood and blood-forming organs, wide

5.95

7.36

1.1

1.0

—

Sleep apnoea, including avohilmo

104

2.62

7.29

1.0

—

Transplanted organ and tissue status

10.86

7.29

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

108

2.59

7.09

1.0

—

Renal tubulo-interstitial diseases

113

2.64

7.06

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

6.01

7.05

1.0

1.1

—

Malaise and fatigue

3.41

6.92

1.0

—

Other diseases of liver

6.31

6.92

1.1

1.0

—

Drug-induced neutropenia

13.80

6.89

1.1

1.0

—

General symptoms and signs

2.48

6.86

1.0

—

Influenza and pneumonia

119

2.46

6.80

1.0

—

Rheumatoid arthritis

4.14

6.69

1.1

—

Persons encountering health services in other circumstances

3.48

6.64

1.0

—

Biological medication for rheuma

5.46

6.59

1.0

1.1

—

Non-follicular lymphoma

12.25

6.57

1.1

1.0

—

Rheumatoid arthritis, including avohilmo

3.64

6.46

1.1

1.0

—

COPD

3.53

6.44

1.0

—

Presence of other functional implants

3.34

6.43

1.0

—

Any reimbursement code in KELA

3.38

6.33

1.1

1.0

—

Implicit viral Sepsis

6.53

6.32

1.1

1.0

—

Tumor necrosis factor alpha inhibitors

5.49

6.28

1.0

1.1

—

Agranulocytosis

9.25

6.28

1.1

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

18.04

6.26

1.1

1.0

—

Heart failure, not strict

2.85

6.16

1.0

—

Viral Sepsis

6.26

6.15

1.1

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

5.95

6.13

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

5.16

5.99

1.0

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

6.01

5.98

1.0

1.1

—

Other septicaemia

3.58

5.96

1.0

1.1

—

Other respiratory diseases principally affecting the interstitium

7.23

5.91

1.1

1.0

—

ILD, hospital admission 2, with pulmonary infections

15.02

5.90

1.1

1.0

—

Other bacterial diseases

111

2.42

5.87

1.0

—

Personal history of other diseases and conditions

7.98

5.81

1.1

1.0

—

COPD/asthma/ILD related infections

2.47

5.77

1.0

—

COPD/asthma related infections

2.47

5.77

1.0

—

Ulcerative colitis (strict definition, require KELA)

5.17

5.69

1.0

1.1

—

Thrombocytopenia, unspecified

12.89

5.58

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.55

5.52

1.0

—

All chronic kidney diseases

2.80

5.50

1.0

—

Other bacterial diseases

112

2.32

5.45

1.0

—

Mucosal proctocolitis

6.20

5.37

1.0

1.1

—

Dyspnoea

115

2.38

5.37

1.0

—

Glomerular disorders in diseases classified elsewhere

11.27

5.28

1.0

—

Abnormal spermatozoa

9.11

5.28

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

5.01

5.24

1.0

1.1

—

COPD, hospital admission 2, with asthma infections

4.73

5.18

1.0

—

Interstitial lung disease

7.34

5.13

1.1

1.0

—

Other interstitial pulmonary diseases

7.34

5.13

1.1

1.0

—

Interstitial lung disease endpoints

7.34

5.13

1.1

1.0

—

Bacterial infection, other or unspecified

2.81

5.04

1.0

1.1

—

Hypopituitarism

10.02

5.02

1.0

—

Heart failure,strict

3.04

4.99

1.0

—

Sleep disorders (combined)

108

2.19

4.99

1.0

—

Adalimumab

6.89

4.95

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

3.08

4.94

1.0

—

Hernia of abdominal wall, postoperative

6.88

4.94

1.0

—

ILD medications: azathioprine

6.01

4.90

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

2.98

4.81

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

4.21

4.80

1.1

1.0

—

Bronchitis

131

2.12

4.75

1.0

—

Azathioprine

5.72

4.74

1.0

—

Glomerular diseases

5.72

4.74

1.0

—

COPD (mode)

5.00

4.74

1.0

—

Asthma, unspecified (mode)

2.98

4.71

1.0

—

ILD-related respiratory insufficiency

14.07

4.58

1.1

1.0

—

Bacterial infection, other or unspecified

2.67

4.58

1.0

1.1

—

Kidney transplant status

14.04

4.57

1.0

—

Excluding asthma or asthma-COPD overlap

2.55

4.54

1.1

1.0

—

Other pulmonary diagnosis

2.55

4.54

1.1

1.0

—

111

2.09

4.52

1.0

—

ILD, hospital admissions

6.67

4.46

1.1

1.0

—

Anaemias

4.45

4.44

1.0

—

All kidney diseases

130

2.10

4.36

1.0

—

Obesity related asthma

3.09

4.35

1.0

—

Other disorders of kidney and ureter

7.51

4.35

1.0

—

Etanercept

11.69

4.27

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

11.69

4.27

1.1

1.0

—

Emphysema

11.69

4.27

1.0

—

Septicaemia

2.87

4.23

1.0

—

ILD, hospital admissions 1, main diag only

6.93

4.16

1.1

1.0

—

COPD differential diagnosis

2.46

4.14

1.1

1.0

—

ILD differential diagnosis

2.46

4.14

1.1

1.0

—

Seronegative rheumatoid arthritis

8.01

4.06

1.0

—

Volume depletion

10.01

4.01

1.0

—

Exposure to unspecified factor

143

2.01

3.97

1.0

—

Enlarged lymph nodes

5.56

3.97

1.1

—

Other specified/unspecified arthritis

3.26

3.90

1.1

1.0

—

Noninfectious colitis NAS

6.01

3.81

1.0

1.1

—

Pulmonary heart disease

3.94

3.78

1.1

1.0

—

Pulmonary embolism

3.94

3.78

1.1

1.0

—

COPD related to multimorbidity

3.00

3.77

1.0

—

Invasive ventilation

8.77

3.77

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

8.76

3.77

1.1

1.0

—

Seropositive rheumatoid arthritis

3.67

3.77

1.1

1.0

—

Other dialysis

12.05

3.76

1.0

—

Ulcerative ileocolitis

12.04

3.76

1.0

—

Heart failure and bmi 25plus

3.09

3.71

1.1

1.0

—

Acute upper respiratory infections

120

2.00

3.71

1.0

—

Persons encountering health services in other circumstances, wide

120

1.93

3.71

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3.59

3.69

1.1

1.0

—

Other/unspecified seropositive rheumatoid arthritis

3.59

3.69

1.1

1.0

—

Ulcerative colitis, NAS

4.41

3.62

1.0

1.1

—

Heart failure, strict

2.50

3.60

1.0

—

Abnormalities of breathing

110

2.01

3.60

1.0

—

Seropositive rheumatoid arthritis, wide

3.50

3.60

1.1

1.0

—

Explicit Sepsis

2.61

3.59

1.0

—

Other arthritis (FG)

2.94

3.56

1.1

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

7.79

3.56

1.0

—

Crohn's disease of small intestine

7.79

3.56

1.0

1.1

—

Asthma, excluding more controls

2.38

3.54

1.0

—

Hypothyroidism, strict autoimmune

2.39

3.53

1.0

—

Obesity

113

2.22

3.53

1.0

—

Obesity and other hyperalimentation

113

2.22

3.52

1.0

—

Diabetic maculopathy, excluding more controls

5.30

3.50

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

10.01

3.49

1.0

—

Exclusions for E4_PCOS_BROAD

3.87

3.48

1.0

1.1

—

Other chronic obstructive pulmonary disease

2.75

3.44

1.0

—

Dental caries

2.89

3.42

1.1

1.0

—

Other disorders of lacrimal gland

2.98

3.40

1.1

1.0

—

Acute renal failure

5.00

3.36

1.0

—

Ulcerative rectosigmoiditis

7.01

3.36

1.0

—

Asthma

2.31

3.35

1.0

—

Nonalcoholic fatty liver disease

5.72

3.34

1.1

1.0

—

GI-bleeding

3.42

3.30

1.1

1.0

—

Medical treatment for female infertility

3.91

3.26

1.0

—

Abnormal findings on diagnostic imaging of lung

2.46

3.24

1.0

—

Caries of dentine

3.01

3.20

1.1

1.0

—

Acute bronchitis

2.66

3.19

1.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

6.38

3.18

1.0

1.1

—

Secondary uncertain malignant neoplasm

6.37

3.18

1.0

—

Duodenal ulcer

6.37

3.18

1.0

—

Erysipelas

2.16

3.18

1.0

—

All-cause Heart Failure

2.39

3.16

1.0

—

Other (seronegative) rheumatoid arthritis, wide

4.50

3.11

1.0

—

Finngen Rheumatological endpoints

114

1.90

3.11

1.0

—

Gastroduodenal ulcer

3.66

3.07

1.0

—

Obesity due to excess calories

2.33

3.07

1.1

1.0

—

Diabetic maculopathy

4.47

3.06

1.0

1.1

—

Other ulcerative colitis

7.52

3.05

1.0

—

Fibrosis and cirrhosis of liver

7.51

3.05

1.0

—

Idiopathic pulmonary fibrosis

7.51

3.05

1.2

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

7.51

3.05

1.2

1.0

—

Heterophoria

7.51

3.05

1.2

1.0

—

Amputation

7.51

3.05

1.0

—

Other heart diseases

2.42

3.03

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

3.18

3.03

1.0

—

Other nutritional deficiencies

118

2.07

3.02

1.0

—

Gout, unspecified

4.29

2.99

1.0

—

Later onset COPD, excluding more controls

5.15

2.98

1.0

—

Other demyelinating diseases of the central nervous system

10.03

2.98

1.0

—

Cirrhosis of liver, NAS

10.02

2.98

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.63

2.96

1.0

—

Heart failure and coronary heart disease

2.64

2.93

1.1

1.0

—

Budesonide

4.71

2.91

1.0

1.1

—

Heart failure and antihypertensive medication

3.41

2.90

1.1

1.0

—

COPD, hospital admissions

2.48

2.89

1.0

—

Osteopathies and chondropathies

2.22

2.88

1.0

—

Gout, FINNGEN

3.43

2.88

1.0

—

Early onset COPD, excluding more controls

4.09

2.87

1.0

—

Hypertension, essential

2.06

2.87

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

5.39

2.86

1.0

—

Methotrexate

5.39

2.86

1.1

1.0

—

Other noninfective gastroenteritis and colitis

3.16

2.84

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

2.18

2.81

1.0

—

Viral infections characterized by skin and mucous membrane lesions

146

1.87

2.78

1.0

—

COPD, early/later onset

2.43

2.78

1.0

—

Other diseases of the digestive system

3.08

2.76

1.1

1.0

—

Acute peritonitis

8.35

2.75

1.0

—

Amputation of toe

8.35

2.75

1.0

—

Collagenous colitis

8.34

2.75

1.0

—

Codes for special purposes

2.16

2.75

1.0

—

Diseases of the skin and subcutaneous tissue

1.86

2.74

1.0

—

Abdominal aortic aneurysm (AAA)

8.27

2.73

1.0

—

Type 2 diabetes, wide definition

1.99

2.73

1.0

—

Zoster [herpes zoster]

5.00

2.72

1.0

—

Cellulitis

3.24

2.72

1.1

—

Mood [affective] disorders

133

1.80

2.72

1.1

1.0

—

Bacterial Sepsis

2.33

2.71

1.0

—

Systemic connective tissue disorders

2.71

1.1

1.0

—

Mood disorders

133

1.80

2.70

1.1

1.0

—

Malignant neoplasm

2.00

2.70

1.0

—

Other complications of surgical and medical care, not elsewhere classified

6.01

2.70

1.0

—

Diseases of peritoneum

6.01

2.70

1.0

—

Enterocolitis due to Clostridium difficile

6.01

2.69

1.0

—

Pleural effusion

6.00

2.69

1.2

1.0

—

Implicit bacterial Sepsis

2.37

2.66

1.1

1.0

—

Certain infectious and parasitic diseases

2.07

2.63

1.0

—

Zoster [herpes zoster]

2.32

2.62

1.0

1.1

—

Venous thromboembolism

2.21

2.61

1.1

1.0

—

Neurological diseases

1.92

2.60

1.0

—

Viral pneumonia

4.67

2.59

1.0

1.1

—

Osteoporosis

3.66

2.58

1.0

—

Gout, strict definition

4.00

2.56

1.0

1.1

—

Any event in cancer register

1.88

2.55

1.0

—

Other and unspecified psoriasis

7.15

2.55

1.0

—

Bronchiectasis

7.15

2.55

1.0

—

Other infectious diseases

7.15

2.55

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

127

1.91

2.55

1.0

—

Disorders of lacrimal system

2.41

2.52

1.1

1.0

—

Diabetes, varying definitions

119

1.77

2.48

1.1

1.0

—

Infections, IBD-co-morbidities

4.08

2.48

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

135

1.76

2.47

1.0

—

Abnormal findings on diagnostic imaging of other body structures

4.38

2.47

1.0

—

Diabetes mellitus

119

1.77

2.46

1.1

1.0

—

Hypertensive diseases

1.93

2.45

1.1

1.0

—

Hypertension

1.93

2.45

1.1

1.0

—

Intestinal infectious diseases

146

1.77

2.45

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.13

2.43

1.0

1.1

—

Dermatitis

109

2.01

2.43

1.0

—

Non-small cell lung cancer, including Hilmo

5.14

2.42

1.0

—

Long labour

3.17

2.42

1.0

1.1

—

Other Crohn's disease

5.01

2.40

1.0

1.1

—

Assault by bodily force

5.01

2.40

1.2

1.1

—

Abnormal results of function studies

5.01

2.40

1.2

1.0

—

Implicit bacterial Sepsis

2.37

2.39

1.0

—

Certain disorders involving the immune mechanism

3.34

2.39

1.0

—

Crohn disease (strict definition, all UC cases excluded)

6.26

2.37

1.0

1.1

—

Pediculosis, acariasis and other infestations

6.26

2.37

1.0

—

Disorders of mineral metabolism

6.26

2.37

1.0

—

Other or unspecified ileus, impaction or obstruction

3.64

2.36

1.0

—

DVT of lower extremities and pulmonary embolism

2.33

2.36

1.1

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

5.31

2.35

1.2

1.0

—

Poisoning by drugs, medicaments and biological substances

2.61

2.35

1.1

1.0

—

Persistent mood disorders

3.03

2.35

1.0

—

Diseases of the respiratory system

2.15

2.35

1.0

—

Diseases of the digestive system

2.20

2.34

1.1

1.0

—

Type 2 diabetes

108

1.79

2.34

1.1

1.0

—

Diabetic retinopathy, strict definition

3.31

2.33

1.0

1.1

—

Depression

132

1.75

2.31

1.1

1.0

—

Neurological diseases, wide definition

2.60

2.30

1.1

1.0

—

Herpesviral [herpes simplex] infections

2.94

2.27

1.0

1.1

—

Herpesviral [herpes simplex] infections

4.62

2.27

1.0

—

Crohn disease

3.48

2.27

1.0

1.1

—

Atrial fibrillation and flutter with reimbursement

3.37

2.26

1.0

—

Gout

2.77

2.25

1.0

—

Persons encountering health services for specific procedures and health care

131

1.69

2.23

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

2.12

2.22

1.0

—

Crohn's disease NAS

5.56

2.21

1.0

—

Other necrotizing vasculopathies

5.56

2.21

1.0

—

Visual field defects

5.56

2.21

1.0

—

Sudden idiopathic hearing loss

5.56

2.21

1.0

—

Hypothyroidism, levothyroxine purchases

2.71

2.20

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.71

2.20

1.0

—

Hypothyroidism (congenital or acquired)

2.71

2.20

1.0

—

Mood disorders, excluding more controls

118

1.72

2.16

1.1

1.0

—

Infective dermatitis

4.29

2.15

1.0

1.1

—

Other acute lower respiratory infections

1.99

2.14

1.0

—

Poisoning by medicine

2.62

2.14

1.1

1.0

—

Disorders of parathyroid gland

3.64

2.12

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

5.01

2.07

1.0

1.1

—

Crohn disease (strict definition, require KELA)

5.01

2.07

1.0

1.1

—

Viral pneumonia (unknown virus, not influenza)

5.01

2.07

1.0

—

Urticaria and erythema

2.26

2.07

1.1

1.0

—

COPD-related respiratory insufficiency

5.00

2.07

1.0

—

Inflammatory diseases of the central nervous system

5.00

2.07

1.0

—

Hydronephrosis

5.00

2.07

1.2

1.0

—

Genitourinary diseases

1.96

2.07

1.0

—

Other gastritis (incl. Duodenitis)

2.90

2.07

1.0

—

Demyelinating diseases of the central nervous system

4.00

2.04

1.2

1.1

—

Other sleep disorders

4.00

2.04

1.2

1.1

—

Complications of labour and delivery

2.07

2.03

1.0

1.1

—

Cardiovascular diseases

1.90

2.03

1.0

—

Certain infectious and parasitic diseases

1.77

2.02

1.0

—

Hyperparathyroidism

3.96

2.01

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.55

2.01

1.0

1.1

—

Psoriasis

2.50

2.01

1.0

—

Other and unspecified dermatitis

2.05

2.00

1.0

1.1

—

Sequelae of external causes of morbidity and mortality

2.63

2.00

1.0

1.1

—

Early onset COPD

2.81

2.00

1.0

—

Complications of surgical and medical care, not elsewhere classified

135

1.67

1.99

1.0

—

Lung cancer and mesothelioma

3.95

1.97

1.0

—

Dermatitis and eczema

141

1.63

1.97

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.34

1.96

1.0

—

3.34

1.96

1.0

—

Malignant neoplasm, wide definition for exclusion

1.77

1.96

1.0

—

Other cataract

2.18

1.96

1.0

—

Peripheral artery operations in Hilmo

4.55

1.94

1.0

—

Substance use, excluding alcohol

2.57

1.94

1.0

1.1

—

Erysipelas

1.99

1.93

1.0

1.1

—

Gout, idiopatic and unspecified

2.73

1.93

1.0

1.1

—

Later onset COPD

3.04

1.92

1.0

—

Suicide or other Intentional self-harm

2.45

1.92

1.0

—

Internal derangement of knee

2.18

1.91

1.0

—

Abdominal and pelvic pain

110

1.64

1.91

1.0

—

Headache

1.88

1.91

1.0

—

Symptoms and signs involving the digestive system and abdomen

110

1.64

1.89

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

120

1.63

1.89

1.1

1.0

—

Implicit Sepsis

1.83

1.89

1.0

—

Chronic apical periodontitis

135

1.60

1.89

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

118

1.69

1.84

1.0

—

Thyroiditis, ILD-related definition

3.53

1.83

1.0

1.1

—

Adjustment and management of implanted device

3.53

1.83

1.0

—

Bacterial, viral and other infectious agents

4.17

1.82

1.0

1.1

—

Hypokalaemia

4.17

1.82

1.0

—

Other embolism and thrombosis

4.17

1.82

1.0

—

Asthma (mode)

1.91

1.82

1.0

—

Type 2 diabetes, definitions combined

100

1.70

1.82

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.21

1.81

1.1

1.0

—

Assault

3.05

1.80

1.1

1.0

—

Spondyloarthritis

3.04

1.79

1.0

—

114

1.78

1.79

1.0

—

Other diseases of urinary system

109

1.65

1.78

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.33

1.77

1.1

1.0

—

Non-ischemic cardiomyopathy

2.59

1.76

1.1

1.0

—

Metabolic disorders

110

1.66

1.76

1.0

—

Constipation

110

1.70

1.75

1.0

—

Diabetic nephropathy, excluding more controls

3.03

1.75

1.0

1.1

—

Other hearing loss

2.70

1.74

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

2.92

1.72

1.0

—

MS-disease / Multiple Sclerosis

3.85

1.71

1.2

1.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

3.85

1.71

1.0

1.1

—

Bacterial, viral and other infectious agents

3.85

1.71

1.0

1.1

—

Open wound of forearm

3.85

1.71

1.0

1.1

—

Other and unspecified iron deficiency

2.29

1.70

1.0

—

Malignant neoplasm of bronchus and lung

3.32

1.70

1.0

1.1

—

Hernia of abdominal wall

1.95

1.69

1.0

—

Asthma (only as main-diagnosis), excluding more controls

1.91

1.69

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

110

1.59

1.68

1.1

1.0

—

113

1.76

1.68

1.0

—

Allergic contact dermatitis

3.16

1.66

1.0

1.1

—

Sequelae with surgical and medical care as external cause

2.80

1.65

1.0

—

Injuries to the neck

2.44

1.64

1.0

—

Hyperkinetic disorders, excluding more controls

2.79

1.63

1.0

—

Acute pharyngitis

2.78

1.63

1.0

—

Diabetic nephropathy

2.77

1.62

1.0

1.1

—

Psoriatic and enteropathic arthropathies

3.57

1.61

1.0

—

Hydrocele

3.57

1.61

1.0

1.1

—

Urticaria

2.14

1.60

1.1

1.0

—

Asthma (only as main-diagnosis)

1.86

1.60

1.0

—

Diagnoses used for exclusion with ILD

2.50

1.59

1.1

1.0

—

Insulin, fast-acting

2.06

1.59

1.0

—

Problems related to lifestyle

3.00

1.58

1.0

1.1

—

Complications of procedures, not elsewhere classified

131

1.64

1.56

1.0

—

Chronic lower respiratory diseases

137

1.52

1.56

1.0

—

Disorders of skin appendages

1.85

1.55

1.0

—

Sleep disorders

131

1.60

1.54

1.1

1.0

—

Insulin, fast-acting or short human

2.03

1.53

1.0

—

Unspecified acute lower respiratory infection

3.33

1.52

1.0

—

Undetermined asthma, excluding more controls

3.33

1.52

1.0

—

Undetermined asthma

3.33

1.52

1.0

—

Depression medications

2.24

1.52

1.2

1.0

—

Benzodiazepine use

147

1.55

1.52

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

2.94

1.51

1.0

1.1

—

External causes of morbidity and mortality

1.78

1.51

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.59

1.51

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.69

1.51

1.0

—

Other and unspecified polyneuropathies, also in other diseases

2.86

1.50

1.0

—

Type 2 diabetes, strict (exclude DM1)

102

1.61

1.48

1.1

1.0

—

Episodal and paroxysmal disorders

116

1.54

1.48

1.0

—

Asthma-related pneumonia

2.07

1.48

1.0

—

Asthma-related pneumonia or sepsis

2.07

1.48

1.0

—

Asthma, hospital admissions 3, pneumonia

2.07

1.48

1.0

—

Alcohol use disorder, Swedish definition

106

1.73

1.47

1.0

—

Other viral diseases

2.06

1.47

1.0

—

Codeine

107

1.57

1.47

1.0

—

Non-rheumatic valve diseases

1.98

1.47

1.0

1.1

—

Atrial fibrillation and flutter

2.43

1.46

1.0

—

Alcohol dependence

2.22

1.46

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

102

1.60

1.44

1.1

1.0

—

Hypothyroidism, other/unspecified

116

1.59

1.44

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

2.79

1.44

1.0

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

3.13

1.44

1.0

1.1

—

Seropositive rheumatoid arthritis, strict definition

3.13

1.44

1.0

—

Myocardial infarction, with ST-elevation

3.13

1.44

1.0

—

Ulcer of lower limb, not elsewhere classified

3.13

1.44

1.0

—

Disorders of eyelid, lacrimal system and orbit

117

1.62

1.43

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.47

1.42

1.0

—

Peritonsillar abscess

2.31

1.42

1.0

—

Intestinal stricture

2.25

1.40

1.0

—

Accidents

1.63

1.39

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.79

1.39

1.1

1.0

—

Iron deficiency anaemia

1.94

1.37

1.0

—

Cardiodefibrillation

2.07

1.37

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

133

1.55

1.37

1.1

1.0

—

Other bacterial intestinal infections

2.61

1.36

1.0

—

Bacterial intestinal infections, IBD co-morbidities

2.61

1.36

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

2.61

1.36

1.2

1.1

—

Acute appendicitis, no complications

111

1.70

1.36

1.1

1.0

—

Infections of the skin and subcutaneous tissue

118

1.68

1.36

1.1

1.0

—

Other and unspecified tonsillitis

1.95

1.36

1.1

1.0

—

Post-traumatic stress disorder

2.94

1.36

1.0

—

Graves disease, strict definition

2.94

1.36

1.0

1.1

—

Cardiomyopathy

2.94

1.36

1.0

1.1

—

Transport accidents

1.84

1.35

1.1

1.0

—

Opioids

109

1.52

1.34

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

118

1.56

1.34

1.0

—

Valvular heart disease excluding rheumatic fever

1.91

1.34

1.0

1.1

—

Speech therapy

0.00

1.34

0.0

1.1

—

Endocrine, nutritional and metabolic diseases

1.61

1.34

1.1

1.0

—

Diabetic retinopathy, excluding more controls

2.24

1.32

1.0

1.1

—

Disorders of thyroid, IBD co-morbidities

2.64

1.32

1.0

—

Impingement syndrome of shoulder

0.00

1.32

0.0

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.03

1.31

1.0

—

Other viral diseases

1.85

1.31

1.0

—

Nausea and vomiting

2.10

1.30

1.1

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.81

1.30

1.1

1.0

—

Fissure and fistula of anal and rectal regions

2.09

1.30

1.1

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.12

1.29

1.0

—

Carpal tunnel syndrome

1.71

1.28

1.0

1.1

—

Spondylopathies (FG)

2.78

1.28

1.0

1.1

—

Insulin, intermediate and long-acting

103

1.70

1.28

1.0

—

Other soft tissue disorders, not elsewhere classified

130

1.49

1.28

1.0

—

Intestinal infectious diseases

136

1.47

1.28

1.0

—

Ventral hernia

2.29

1.26

1.0

—

Pacemaker

2.25

1.25

1.1

1.0

—

Emotionally unstable personality disorder

2.40

1.24

1.2

1.0

—

Nonorganic sleeping disorders, excluding more controls

2.22

1.24

1.1

1.0

—

Colonic or urogenital fistula

2.00

1.23

1.1

1.0

—

Disorders of gallbladder, biliary tract and pancreas

116

1.52

1.23

1.0

—

Type 1 diabetes

2.00

1.23

1.0

—

Depression or dysthymia

1.61

1.22

1.1

1.0

—

Implicit Sepsis

112

1.57

1.22

1.0

—

Injuries to the elbow and forearm

122

1.59

1.21

1.0

—

Other heart diseases, wide

113

1.51

1.20

1.0

—

Codeine or tramadol medication

132

1.45

1.20

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.75

1.19

1.1

1.0

—

Inguinal hernia

0.45

1.19

1.0

—

Insulin, fast-acting (human)

2.31

1.18

1.0

1.1

—

Other external causes of accidental injury

1.57

1.18

1.0

—

Other degenerative diseases of the nervous system

2.13

1.18

1.1

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.88

1.17

1.1

1.0

—

Fibroblastic disorders

0.00

1.16

0.0

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

102

1.67

1.15

1.1

1.0

—

Colectomy operation

2.50

1.15

1.0

—

Nonorganic sleeping disorders

2.05

1.15

1.1

1.0

—

Diabetic retinopathy

1.92

1.15

1.0

1.1

—

Other medical care

1.77

1.15

1.0

1.1

—

Other disorders of urethra and urinary system

1.63

1.14

1.0

—

Hypo-osmolality and hyponatraemia

2.49

1.14

1.0

1.1

—

Mental and behavioural disorders due to alcohol

106

1.63

1.13

1.0

—

Oxycodone

1.91

1.12

1.0

—

Asthma (diagnoses ohter than nonallergic)

151

1.48

1.12

1.0

—

Psoriasis vulgaris

2.33

1.12

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

117

1.58

1.12

1.0

—

Paralytic ileus and intestinal obstruction

2.00

1.12

1.0

—

Other anxiety disorders

1.66

1.11

1.0

—

Cerebrovascular diseases (FINNGEN)

2.02

1.11

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

106

1.53

1.11

1.0

—

Recurrent or chronic depression

1.73

1.10

1.0

—

Diseases of oesophagus, stomach and duodenum

133

1.44

1.09

1.0

—

Viral and other specified intestinal infections

1.95

1.09

1.1

1.0

—

Nonsuppurative otitis media

1.97

1.09

1.1

1.0

—

Other strabismus

1.94

1.08

1.1

1.0

—

Other viral diseases, not elsewhere classified

2.18

1.07

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

128

1.48

1.07

1.1

1.0

—

Disorders of choroid and retina

107

1.53

1.07

1.0

—

Aortic aneurysm

2.15

1.06

1.0

1.1

—

Hyperkinetic disorders

2.14

1.06

1.0

—

Cystitis

1.52

1.06

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

110

1.58

1.05

1.0

—

All influenza

2.12

1.05

1.0

—

Disorders of the thyroid gland

125

1.46

1.05

1.0

—

Nutritional anaemias

1.71

1.04

1.0

—

Other systemic involvement of connective tissue (FG)

2.09

1.04

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

0.55

1.03

1.1

1.0

—

Other symptoms and signs involving the digestive system and abdomen

2.27

1.03

1.2

1.0

—

Gastrointestinal diseases

1.61

1.03

1.1

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.89

1.02

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.83

1.02

1.0

—

Cutaneous abscess, furuncle and carbuncle

1.92

1.02

1.0

—

Strabismus

1.91

1.01

1.1

1.0

—

Other viral diseases, not elsewhere classified

1.90

1.01

1.0

—

Acute sinusitis

1.65

1.00

1.1

1.0

—

Visual disturbances and blindness

1.65

1.00

1.1

1.0

—

Car occupant injured in other and unspecified transport accidents

2.00

1.00

1.0

1.1

—

Other bacterial intestinal infections

2.00

1.00

1.0

—

Calcific aortic valvular stenosis, operated

2.00

0.99

1.0

—

Calcific aortic valvular stenosis

2.00

0.99

1.0

—

Operations 2 for CAVS

2.00

0.99

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.00

0.99

1.0

—

Anxiety disorders

130

1.45

0.99

1.1

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

1.99

0.99

1.0

—

Insulin medication

103

1.55

0.98

1.0

—

Acute alcohol intoxication

1.84

0.98

1.0

—

Other/unspecified dorsalgia

1.75

0.97

1.0

—

Intracranial trauma

1.63

0.97

1.1

1.0

—

Visual disturbances

1.67

0.97

1.1

1.0

—

Concussion

1.68

0.97

1.1

1.0

—

Other diseases of upper respiratory tract

123

1.40

0.97

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

115

1.47

0.97

1.0

—

Conduction disorders

1.96

0.96

1.1

—

Umbilical hernia

1.80

0.96

1.0

—

Mouth breathing

1.74

0.96

1.1

1.0

—

Dental pulpitis, including avohilmo

133

1.41

0.95

1.0

—

Tramadol

1.50

0.95

1.0

—

Iridocyclitis

1.89

0.94

1.0

1.1

—

Other systemic involvement of connective tissue

1.89

0.94

1.1

1.0

—

Insomnia

132

1.43

0.93

1.0

—

Postpartum care and examination

2.24

0.93

1.0

1.1

—

Acute appendicitis

132

1.49

0.93

1.0

—

Sub-endpoint used in defining T1D endpoints

1.74

0.92

1.0

—

Personality disorders

1.73

0.92

1.1

1.0

—

Pregnancy examination and test

2.19

0.92

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

2.15

0.91

1.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

2.14

0.91

1.0

1.1

—

Other disorders of ear

108

1.45

0.91

1.1

1.0

—

Benign neoplasms

149

0.67

0.90

1.0

—

Anxiety disorders, excluding more controls

113

1.44

0.90

1.1

1.0

—

Other obstetric conditions, not elsewhere classified

1.79

0.90

1.0

1.1

—

Coxarthrosis, primary

0.49

0.90

1.0

—

Other diseases of intestines

137

1.37

0.89

1.0

—

Other antidepressants

123

1.37

0.89

1.1

1.0

—

Bacterial pneumonia (organism specified)

1.66

0.89

1.1

1.0

—

Solid cancers, helper endpoint

1.49

0.89

1.0

—

Acute alcohol intoxication, ICD10

1.91

0.88

1.0

—

Use of hypnotics and sedatives

124

1.39

0.88

1.0

—

Diseases of oral cavity, salivary glands and jaws

0.56

0.88

1.0

—

Obesity, other/unspecified

1.79

0.87

1.1

1.0

—

Psychiatric diseases

108

1.39

0.87

1.0

—

Papulosquamous disorders

1.72

0.86

1.0

—

Disturbance of activity and attention

1.96

0.85

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.49

0.85

1.1

1.0

—

Diseases of male genital organs

1.54

0.84

1.0

—

Gestational diabetes (for exclusion)

1.74

0.84

1.0

—

Hypertensive diseases (excluding secondary)

1.63

0.83

1.1

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

113

1.37

0.83

1.1

1.0

—

Other disorders of skin and subcutaneous tissue

107

1.49

0.82

1.0

—

Pain (limb, back, neck, head abdominally)

1.42

0.82

1.1

1.0

—

Anterior Iridocyclitis

1.88

0.81

1.0

1.1

—

Chronic sinusitis

1.64

0.81

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

1.72

0.81

1.0

—

Excessive, frequent and irregular menstruation

1.69

0.80

1.0

1.1

—

Prolonged pregnancy

0.00

0.79

0.0

1.0

—

Anxiety (asthma-related co-morbidities)

100

1.47

0.79

1.1

1.0

—

Congenital malformations of the circulatory system

0.00

0.79

0.0

1.0

—

Care involving use of rehabilitation procedures

1.52

0.79

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

137

0.60

0.79

1.0

—

Lichen planus, including avohilmo

0.00

0.79

0.0

1.0

—

1.59

0.78

1.0

—

Specific personality disorders

1.67

0.78

1.1

1.0

—

1.67

0.78

1.0

—

Percutaneous Coronary Intervention

1.46

0.78

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.46

0.78

1.1

1.0

—

Oedema, not elsewhere classified

1.79

0.77

1.0

—

Other congenital malformations

0.00

0.77

0.0

1.0

—

Pediculosis, acariasis and other infestations

1.77

0.76

1.0

1.1

—

Single delivery by caesarean section

1.91

0.76

1.0

1.1

—

Substance abuse

116

1.46

0.75

1.0

—

Nerve, nerve root and plexus disorders

137

1.34

0.75

1.0

—

Substance abuse, excluding more controls

105

1.46

0.75

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.08

0.74

1.0

—

Other disorders of veins

1.69

0.74

1.1

1.0

—

Labour and delivery complicated by fetal stress [distress]

1.83

0.73

1.0

1.1

—

Supervision of high-risk pregnancy

1.83

0.73

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.64

0.73

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.84

0.73

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.64

0.73

1.1

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.64

0.73

1.1

1.0

—

Injuries to the head

149

1.32

0.73

1.0

—

Acute tubulo-interstitial nephritis

1.48

0.72

1.0

—

Asthma, including avohilmo

146

1.31

0.72

1.0

—

Cough

1.63

0.72

1.0

—

Arthropathies

105

1.35

0.72

1.0

—

Appendicitis, broad definition

136

1.40

0.71

1.0

—

Injury, poisoning and certain other consequences of external causes

1.53

0.71

1.1

1.0

—

Shoulder lesions

0.62

0.71

1.1

1.0

—

Migraine with aura and triptan purchases

1.92

0.70

1.0

—

All influenza (not pneumonia)

1.92

0.70

1.0

—

severe traumatic brain injury, does not include concussion

1.92

0.70

1.0

—

Preterm labour and delivery

1.92

0.70

1.0

1.1

—

Pain in limb

123

1.36

0.70

1.0

—

Diseases of appendix

136

1.39

0.70

1.0

—

Caries of enamel

149

0.68

0.70

1.0

—

Personality disorders, excluding more controls

1.55

0.69

1.1

1.0

—

Dermatophytosis

126

1.43

0.69

1.1

1.0

—

Maternal care for other known or suspected fetal problems

1.70

0.69

1.0

1.1

—

Tonsillectomy and adenotomy

1.44

0.69

1.1

1.0

—

Thyrotoxicosis, other and/or unspecified

1.85

0.68

1.0

—

Benign paroxysmal vertigo

1.67

0.68

1.0

—

Single delivery by forceps and vacuum extractor

1.88

0.68

1.0

1.1

—

Diseases of external ear

1.53

0.68

1.0

—

Type 1 diabetes, wide definition

1.67

0.68

1.0

—

Superficial injury of lower leg

1.63

0.66

1.0

—

Disorders of lens

1.47

0.66

1.0

—

Artificial joint operation, meniscal resection

125

0.67

0.66

1.0

—

Cholelithiasis, broad definition with cholecystitis

102

1.39

0.66

1.0

—

Emergency coronary revascularization (for ACS)

1.39

0.66

1.0

—

Intracranial injury

113

1.42

0.65

1.1

1.0

—

Other and unspecified urticaria

1.72

0.64

1.0

—

Bleeding

109

1.37

0.63

1.0

—

Complications of medical and surgical care

126

1.39

0.63

1.0

—

All anxiety disorders

108

1.39

0.63

1.1

1.0

—

Maternal care for known or suspected malpresentation of fetus

1.73

0.63

1.0

1.1

—

Unspecified haematuria

1.53

0.62

1.0

—

Gonarthrosis, primary, with knee surgery

0.57

0.62

1.2

1.0

—

Diabetes medication

127

1.31

0.62

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.67

0.61

1.0

1.1

—

Paroxysmal tachycardia

1.67

0.61

1.0

—

In situ neoplasms

1.60

0.61

1.1

1.0

—

Hyperlipidaemia, other/unspecified

1.59

0.61

1.1

1.0

—

Congenital malformations of heart and great arteries

0.00

0.60

0.0

1.1

—

Certain conditions originating in the perinatal period

0.00

0.60

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.60

0.0

1.1

—

Adenomyosis (Endometriosis of uterus)

0.00

0.60

0.0

1.1

—

Other and unspecified effects of external causes

1.57

0.60

1.0

—

Deforming dorsopathies

1.57

0.60

1.0

—

Coronary revascularization (ANGIO or CABG)

1.38

0.60

1.1

1.0

—

Rheumatism, unspecified

0.00

0.60

0.0

1.0

—

Palmar fascial fibromatosis [Dupuytren]

0.00

0.60

0.0

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.45

0.60

1.0

—

Presence of other devices

0.00

0.60

0.0

1.0

—

Cholelithiasis

101

1.36

0.59

1.1

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.57

0.59

1.0

—

Other reaction to severe stress, and adjustment disorders

1.53

0.59

1.1

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

0.61

0.58

1.0

—

Other disorders of eye and adnexa

0.00

0.58

0.0

1.0

—

Candidiasis

0.00

0.58

0.0

1.0

—

Convulsions, not elsewhere classified

1.74

0.58

1.0

—

Caries of dentine, including avohilmo

1.36

0.58

1.1

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.71

0.57

1.0

1.1

—

Retention of urine

1.49

0.57

1.0

—

Injuries to the knee and lower leg

145

1.26

0.57

1.0

—

Cardiac arrhythmias

1.43

0.57

1.0

—

Tinnitus

1.67

0.56

1.2

1.1

—

Any mental disorder

122

1.27

0.56

1.1

1.0

—

Diabetes mellitus in pregnancy

1.56

0.56

1.0

1.1

—

Postpartum haemorrhage

1.63

0.55

1.0

1.1

—

Thyrotoxicosis

1.62

0.55

1.0

—

Injuries to the wrist and hand

152

1.28

0.55

1.0

—

Atopic dermatitis, strict definition

1.52

0.54

1.0

—

Unspecified fall

1.44

0.54

1.1

1.0

—

Superficial injury of wrist and hand

1.58

0.54

1.0

1.1

—

Viral and other specified intestinal infections

1.53

0.54

1.1

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

106

1.40

0.54

1.0

—

Other and unspecified disorders of vitreous body

1.48

0.53

1.0

—

Bacterial pneumoniae

1.47

0.53

1.0

—

Necrosis of pulp, including avohilmo

116

1.38

0.53

1.1

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.60

0.53

1.0

—

Infections with a predominantly sexual mode of transmission

1.43

0.52

1.2

1.0

—

Benign neoplasm: Colon

0.62

0.52

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

127

0.67

0.51

1.0

—

Artrosis, including avohilmo

106

0.72

0.51

1.0

—

Haemorrhage in early pregnancy

1.50

0.51

1.0

1.1

—

Noninflammatory disorders of female genital tract

1.47

0.49

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

1.57

0.49

1.0

—

Asthma-related infections

116

1.35

0.49

1.0

—

Asthma, hospital admission 2, infections

116

1.35

0.49

1.0

—

Antenatal screening

1.51

0.48

1.0

—

Other retinal disorders

1.35

0.48

1.0

—

Procreative management

1.49

0.48

1.1

1.0

—

Actinic keratosis

1.51

0.48

1.0

—

Leiomyoma of uterus

0.58

0.47

1.2

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

121

1.27

0.47

1.0

—

Disorders of vitreous body

1.44

0.46

1.0

—

Fracture of foot, except ankle

1.43

0.46

1.0

—

Glaucoma suspect

1.43

0.46

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.43

0.46

1.1

1.0

—

Disorders of refraction and accommodation

1.42

0.45

1.1

1.0

—

Other diseases of hard tissues of teeth

0.70

0.45

1.1

1.0

—

Appendectomy

124

1.31

0.44

1.0

—

Scabies

1.61

0.43

1.0

1.1

—

Panic disorder

1.61

0.43

1.2

1.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.61

0.43

1.0

—

Haemorrhage from respiratory passages

1.44

0.43

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.37

0.42

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.44

0.42

1.1

1.0

—

Abnormalities of heart beat

1.43

0.42

1.1

1.0

—

Major coronary heart disease event excluding revascularizations

1.37

0.42

1.0

—

Bacterial pneumonia, not elsewhere classified

1.41

0.42

1.0

—

Acute suppurative otitis media

1.41

0.42

1.0

—

Alcohol use disorder, ICD-based

1.38

0.42

1.0

—

Disorders of adult personality and behaviour

1.40

0.42

1.1

1.0

—

Non-invasive ventilation

1.54

0.42

1.2

1.0

—

Symptoms and signs involving the urinary system

113

1.28

0.41

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.28

0.41

1.0

—

Speech and linguistic disorders

0.00

0.41

0.0

1.1

—

Parkinson's disease, excluding more controls

0.00

0.41

0.0

1.0

—

Dysphagia

1.52

0.41

1.0

—

Type 1 diabetes, strict definition

0.00

0.41

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.41

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.41

0.0

1.1

—

Other and unspecified mood [affective] disorders

0.00

0.41

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.41

0.0

1.1

—

Metatarsalgia

0.00

0.41

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.41

0.0

1.1

—

Parkinson's disease

0.00

0.41

0.0

1.0

—

Exposure to other specified factors

145

1.27

0.41

1.0

—

Overexertion and strenuous or repetitive movements

0.00

0.41

0.0

1.1

—

Perforation of tympanic membrane

0.00

0.41

0.0

1.1

—

Plantar fascial fibromatosis

0.00

0.41

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.41

0.0

1.1

—

Fracture of lower leg, including ankle

104

1.33

0.40

1.0

—

Impacted maxillary molar

0.00

0.40

0.0

1.1

—

Other shoulder lesions

0.00

0.40

0.0

1.1

—

0.00

0.40

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.40

0.0

1.0

—

Inguinal hernia, bilateral

0.00

0.40

0.0

1.1

—

Inguinal or femoral hernia, bilateral

0.00

0.40

0.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.40

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.34

0.40

1.0

—

Allergic rhinitis

1.34

0.40

1.0

—

Triptan medication for migraine, single purchase ok

119

1.25

0.40

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

119

1.25

0.40

1.0

—

Pilonidal cyst

0.00

0.40

0.0

1.1

—

Contact with machinery

0.00

0.40

0.0

1.1

—

Bell's palsy

0.00

0.40

0.0

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.34

0.39

1.2

1.0

—

Premature rupture of membranes

1.43

0.39

1.0

—

Gonarthrosis,primary

0.75

0.39

1.0

—

Open wound of wrist and hand

1.34

0.39

1.0

—

Low back pain

127

1.24

0.38

1.0

—

Adverse effects, not elsewhere classified

1.39

0.38

1.0

1.1

—

Peripheral artery disease

1.33

0.38

1.0

—

Disorders of vitreous body and globe

1.37

0.37

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.30

0.37

1.1

1.0

—

Vasomotor and allergic rhinitis

1.30

0.37

1.0

—

Malignant neoplasm of skin

1.40

0.36

1.0

—

Gastro-oesophageal reflux disease

108

1.28

0.36

1.0

—

Coxarthrosis, primary, with hip surgery

0.66

0.35

1.0

—

Postpartum hemorraghe, all women as controls

1.44

0.35

1.0

—

Other intervertebral disc disorders

115

0.78

0.35

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.40

0.35

1.0

—

Postpartum hemorraghe, parous women as controls

1.38

0.35

1.0

—

Redundant prepuce, phimosis and paraphimosis

1.38

0.34

1.0

—

Subjective visual disturbances

1.36

0.34

1.0

—

Migraine with aura

1.33

0.33

1.0

—

Primary gonarthrosis, bilateral

0.69

0.33

1.2

1.0

—

Other symptoms and signs involving cognitive functions and awareness

0.68

0.33

1.0

—

Mycoses

1.30

0.33

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.28

0.32

1.0

—

Other joint disorders

105

1.21

0.32

1.0

—

Hernia

128

1.20

0.31

1.0

—

malignant neoplasm of male genital organs

1.33

0.31

1.0

1.1

—

Mycoses

159

1.20

0.31

1.1

1.0

—

Melanocytic naevi

1.35

0.31

1.0

—

Pain in throat and chest

104

1.21

0.30

1.0

—

Major coronary heart disease event

1.23

0.30

1.1

1.0

—

Infections with a predominantly sexual mode of transmission

1.31

0.30

1.2

1.0

—

Sulfonylureas

1.27

0.30

1.0

—

Disorders of sclera, cornea, iris and ciliary body

102

1.27

0.30

1.0

—

Ischemic heart diseases

1.23

0.29

1.1

1.0

—

Factors influencing health status and contact with health services

1.30

0.29

1.0

—

Diaphragmatic hernia

1.23

0.29

1.0

—

Pregnancy with abortive outcome

0.75

0.28

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

137

0.79

0.28

1.0

—

Stroke, including SAH

0.76

0.28

1.1

1.0

—

Rotator cuff syndrome

0.75

0.28

1.1

1.0

—

Syncope and collapse

1.27

0.28

1.0

—

Propionic acid derivatives

0.66

0.27

1.2

1.0

—

Neoplasms

1.19

0.27

1.0

—

Biguanides

113

1.19

0.27

1.0

—

Parasetamol

1.20

0.27

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.25

0.26

1.0

—

Hyperplasia of prostate

1.28

0.26

1.0

—

Coxarthrosis

0.66

0.26

1.0

—

Embedded and impacted teeth

0.69

0.26

1.0

—

Striking against or struck by other objects

1.19

0.26

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

104

1.25

0.26

1.0

—

Ischaemic heart disease, wide definition

1.22

0.26

1.0

—

Dorsopathies

131

0.85

0.25

1.0

—

Other arthrosis

0.73

0.24

1.2

1.0

—

Coxarthrosis [arthrosis of hip](FG)

0.74

0.24

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

114

1.21

0.24

1.0

—

Atopic dermatitis

1.22

0.23

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

108

1.17

0.23

1.0

—

Otitis externa

1.28

0.23

1.0

1.1

—

Spinal stenosis

0.75

0.22

1.0

—

Selective serotonin reuptake inhibitors

123

1.15

0.22

1.0

—

Meniscus derangement

0.73

0.22

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.18

0.22

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

144

0.85

0.22

1.0

—

Other disorders of bone

1.25

0.22

1.0

1.1

—

Primary coxarthrosis, bilateral

1.25

0.22

1.0

—

Postmenopausal bleeding

1.21

0.22

1.2

1.0

—

Suppurative and unspecified otitis media

1.27

0.22

1.0

—

Unspecified dementia

0.00

0.21

0.0

1.0

—

Foreign body or object entering through skin

0.00

0.21

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.1

—

Inflammatory disorders of breast

0.00

0.21

0.0

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

1.1

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.1

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Spirochaetal infections, other/unspecified

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.21

0.0

1.0

—

Memory loss

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.0

—

Other peripheral vertigo

0.00

0.21

0.0

1.0

—

Other congenital malformations

0.00

0.21

0.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

1.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.1

—

Benign neoplasm of eye and adnexa

0.00

0.21

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.0

—

Use of rivastigmine

0.00

0.21

0.0

1.0

—

Diseases of the eye and adnexa

1.16

0.21

1.0

—

Medical observation and evaluation for suspected diseases and conditions

0.83

0.21

1.0

—

Varicose veins

0.76

0.21

1.1

1.0

—

Other congenital malformations of skin

0.00

0.21

0.0

1.1

—

Ocular pain

0.00

0.21

0.0

1.1

—

Benign neoplasm: Caecum

0.00

0.21

0.0

1.0

—

Unspecified/other endometriosis

0.00

0.21

0.0

1.1

—

Glaucoma, exfoliation

0.00

0.21

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.0

—

Other (not insulin) diabetes medications

113

1.15

0.21

1.1

1.0

—

Antihypertensive medication - note that there are other indications

1.19

0.21

1.1

1.0

—

Diseases of tongue

0.00

0.21

0.0

1.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.0

—

Other disorders of cornea

0.00

0.21

0.0

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.21

0.0

1.0

—

Lichen planus

0.00

0.21

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.20

0.0

1.0

—

Angina pectoris

1.24

0.20

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

0.20

0.0

1.0

—

Recurrent dislocation of patella

0.00

0.20

0.0

1.1

—

Deep endometriosis

0.00

0.20

0.0

1.0

—

Fall on same level involving ice and snow

108

1.20

0.20

1.0

—

Combinations of oral blood glucose lowering drugs

1.22

0.20

1.0

—

Cerebrovascular diseases

0.82

0.19

1.1

1.0

—

Female infertility

1.17

0.19

1.0

—

Pre-eclampsia or poor fetal growth

1.20

0.19

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.19

0.19

1.0

—

Calculus of kidney and ureter

1.18

0.19

1.0

1.1

—

Irritable bowel syndrome

1.18

0.19

1.0

—

Dental caries, including avohilmo

1.18

0.19

1.1

1.0

—

Disturbances of skin sensation

1.15

0.19

1.0

—

Other maternal disorders predominantly related to pregnancy

1.23

0.19

1.0

—

Type of accident

1.13

0.18

1.0

—

Spondylosis

1.21

0.18

1.0

—

Basal cell carcinoma

1.21

0.18

1.0

1.1

—

Delivery, wide proxy

1.16

0.18

1.0

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.18

0.18

1.0

—

Keratitis

1.19

0.18

1.0

—

Diseases of middle ear and mastoid

1.18

0.17

1.1

1.0

—

Myocardial infarction, without ST-elevation

1.16

0.17

1.0

—

Single spontaneous delivery

0.74

0.17

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.13

0.17

1.0

—

Haemorrhoids and perianal venous thrombosis

1.13

0.17

1.0

1.1

—

Diseases of the ear and mastoid process

126

1.12

0.17

1.0

—

Delivery

1.17

0.17

1.0

1.1

—

Fracture at wrist and hand level

1.11

0.17

1.0

—

Schizophrenia or delusion, excluding more controls

0.73

0.17

1.0

—

Diseases of arteries, arterioles and capillaries

1.17

0.17

1.0

—

Triptan medication for migraine, min. 3 purchases

1.18

0.16

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.21

0.16

1.1

1.0

—

Hard cardiovascular diseases

1.15

0.16

1.1

1.0

—

Conjunctivitis

132

1.14

0.15

1.1

1.0

—

Disorders of breast

0.79

0.15

1.0

—

Other specific joint derangements/joint disorders

102

1.14

0.15

1.0

—

Spontaneous abortion

1.12

0.15

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.18

0.15

1.2

1.0

—

Fracture of forearm

1.19

0.14

1.1

1.0

—

Unspecified mental disorder

0.81

0.14

1.0

—

Lumbar disc prolapse

107

0.86

0.14

1.0

—

Chronic periodontitis, complicated

0.83

0.13

1.0

—

Spondylopathies

101

1.12

0.13

1.0

—

Injuries to the ankle and foot

134

1.13

0.13

1.1

1.0

—

Coronary atherosclerosis

1.17

0.13

1.0

—

Stroke, excluding SAH

0.82

0.13

1.1

1.0

—

Excessive earwax

101

1.16

0.13

1.2

1.0

—

Pure hypercholesterolaemia

1.14

0.12

1.0

—

Injuries to the hip and thigh

1.18

0.12

1.1

1.0

—

Asthma, hospital admissions , main diagnosis only

151

1.11

0.12

1.0

—

Dizziness and giddiness

117

0.88

0.12

1.0

—

Open wound of head

110

1.14

0.11

1.0

—

Allergic conjunctivitis

102

1.15

0.11

1.2

1.0

—

Polycystic ovarian syndrome, consortium definition

0.87

0.11

1.0

—

Persons encountering health services in circumstances related to reproduction

1.12

0.10

1.0

—

Periodontitis

135

1.09

0.10

1.1

1.0

—

Hypertensive heart and/or renal disease

1.13

0.10

1.2

1.0

—

Gonarthrosis

1.14

0.09

1.0

—

Pedal cyclist injured in transport accident

1.09

0.09

1.0

—

Erosion of teeth , including avohilmo

1.09

0.09

1.0

—

Epilepsy

1.06

0.09

1.0

—

Disorders of synovium and tendon

1.13

0.09

1.0

—

Soft tissue disorders related to use, overuse and pressure

1.04

0.09

1.0

—

Menorrhagia

1.11

0.09

1.0

1.1

—

Retinal detachments and breaks

1.11

0.09

1.0

—

Other diseases of anus and rectum

1.09

0.08

1.0

1.1

—

Conjunctivitis (acute, non atopic)

1.09

0.08

1.0

—

Disorders of conjunctiva

140

1.09

0.08

1.1

1.0

—

Urolithiasis

1.07

0.08

1.0

1.1

—

Other abnormal products of conception

1.04

0.08

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.05

0.08

1.0

—

Chronic diseases of tonsils and adenoids

104

1.09

0.08

1.1

1.0

—

Basal cell carcinoma, including avohilmo

1.03

0.08

1.0

1.1

—

Deviated nasal septum

0.81

0.08

1.2

1.0

—

Non-selective monoamine reuptake inhibitors

0.78

0.08

1.0

—

Schizophrenia or delusion

0.77

0.08

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.77

0.08

1.0

—

Statin medication

0.90

0.08

1.1

1.0

—

Acetic acid derivatives and related substances

0.84

0.08

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.79

0.08

1.2

1.0

—

Coxibs

1.11

0.08

1.0

—

Other headache syndromes

1.04

0.08

1.0

—

Fracture of shoulder and upper arm

1.04

0.08

1.0

—

Gingivitis and periodontal diseases

122

0.93

0.07

1.1

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.83

0.07

1.0

—

Myocardial infarction, strict

1.10

0.07

1.0

—

Disorders of vestibular function (Vertigo)

1.08

0.07

1.0

1.1

—

Dental operations

1.11

0.07

1.1

1.0

—

Myocardial infarction

1.02

0.07

1.0

—

Fall on same level

151

0.94

0.07

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.84

0.07

1.1

1.0

—

Periapical abscess

0.83

0.07

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.10

0.07

1.0

—

Chronic periodontitis, including avohilmo

137

0.93

0.07

1.2

1.0

—

Other functional intestinal disorders

1.06

0.07

1.0

1.1

—

Contraceptive management

0.88

0.07

1.0

—

STROKE

0.85

0.07

1.0

—

Other neurological diseases

112

0.91

0.06

1.1

1.0

—

Soft tissue disorders

131

1.06

0.06

1.0

—

Ischaemic Stroke, excluding all haemorrhages

0.87

0.06

1.1

1.0

—

Sciatica+with lumbago

0.89

0.06

1.0

1.1

—

Conductive and sensorineural hearing loss

1.09

0.06

1.1

1.0

—

Lower back pain or/and sciatica

154

1.06

0.06

1.0

—

Sensorineural hearing loss

1.09

0.06

1.1

1.0

—

Injuries to the shoulder and upper arm

147

0.93

0.06

1.0

—

Any death

1.10

0.06

1.0

—

Diseases of inner ear

1.11

0.05

1.0

—

Other arrhythmias

1.09

0.04

1.0

—

Migraine

1.10

0.03

1.0

—

Asthma/COPD (KELA code 203)

137

0.95

0.03

1.0

—

Other dorsopathies, not elsewhere classified

131

0.96

0.03

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

127

1.05

0.03

1.0

—

Pain in joint

1.06

0.02

1.0

—

Glaucoma

1.08

0.02

1.0

—

Inflammatory diseases of female pelvic organs

1.06

0.01

1.2

1.0

—

Falls/tendency to fall

132

1.02

0.00

1.0

—

Diverticular disease of intestine

0.96

0.00

1.0

—

Medical abortion

0.96

0.00

1.0

—

Persons encountering health services for examination and investigation

0.99

0.00

1.1

1.0

—

Dentofacial anomalies [including malocclusion]

121

1.00

0.00

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

103

1.01

0.00

1.0

—

Dorsalgia

131

1.02

0.00

1.0

—

Senile cataract

1.00

0.00

1.0

—

Arthrosis

1.03

0.00

1.0

—

Cholecystectomy

108

0.96

0.00

1.1

1.0

—

Examination and observation for other reasons

1.01

0.00

1.1

1.0

—

Excessive attrition of teeth

118

1.02

0.00

1.1

1.0

—

Disease of hard tissues of teeth, NOS

1.00

0.00

1.1

1.0

—

Malignant neoplasm of prostate, including Hilmo

0.96

0.00

1.0

1.1

—

Impacted cerumen

0.00

0.0

1.0

—

Bullous disorders

0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

0.0

1.0

—

Wide developmental disorders

0.00

0.0

1.2

—

Oligomenorrhoea

0.00

0.0

1.2

—

Barrett oesophagus

0.00

0.0

1.0

—

Bicuspidal aortic valve syndrome

0.00

0.0

1.0

—

Thyroiditis

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

0.0

1.0

—

Unspecified misadventure during surgical and medical care

0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

0.0

1.2

—

Benign neoplasm: Skin of trunk

0.00

0.0

1.0

—

Use of biperiden

0.00

0.0

1.0

—

Other infective otitis externa

0.00

0.0

1.0

—

Generalized epilepsy

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.0

—

Bicipital tendinitis

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.0

—

Atypical facial pain

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

1.0

—

Right hemicolectomy

0.00

-0.00

0.0

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Habitual aborter

0.00

-0.00

0.0

1.0

—

Persistent delusional disorders

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Other secondary gonarthrosis

0.00

-0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

-0.00

0.0

1.0

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Bulimia nervosa (incl. atypical)

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Glucosamine medication

0.98

-0.00

1.2

1.0

—

Convergent concomitant strabismus

0.00

-0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

1.0

—

Autism

0.00

-0.00

0.0

1.2

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.1

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Dystonia

0.00

-0.00

0.0

1.0

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.0

—

LeFortI or BSSO operation

0.00

-0.00

0.0

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.1

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.0

—

Cholesteatoma of middle ear

0.00

-0.00

0.0

1.0

—

Vascular disorders of the intestines

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Adrenal gland

0.00

-0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.2

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Congenital malformations of cardiac septa

0.00

-0.00

0.0

1.1

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

L01XX Other antineoplastic agents

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Endometriosis

1.01

-0.00

1.0

1.1

—

Arterial embolism and thrombosis

0.00

-0.00

0.0

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.1

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Small fibre neuropathy

0.00

-0.00

0.0

1.0

—

Special screening examination for neoplasms

0.00

-0.00

0.0

1.0

—

Polyp of the female genital tract

1.03

-0.00

1.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS